Anti-inflammatory effects of naringin in chronic pulmonary neutrophilic inflammation in cigarette smoke-exposed rats

Journal of Medicinal Food

Volumn 15, Issue 10, 2012, Pages 894-900

  Nie, Yi Chu ^a   Wu, Hao ^b   Li, Pei Bo ^a   Luo, Yu Long ^a   Long, Kang ^a   Xie, Li Ming ^a   Shen, Jian Gang ^b   Su, Wei Wei ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

anti inflammatory effect; chronic pulmonary neutrophilic inflammation; cigarette smoke; naringin; rats

Indexed keywords

AURANTIIN; CIGARETTE SMOKE; EOSIN; GELATINASE B; HEMATOXYLIN; INTERLEUKIN 10; INTERLEUKIN 8; MYELOPEROXIDASE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS; CHRONIC PULMONARY NEUTROPHILIC INFLAMMATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG DISEASE; LUNG LAVAGE; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FLAVANONES; INTERLEUKIN-10; INTERLEUKIN-8; MALE; MATRIX METALLOPROTEINASE 9; NEUTROPHILS; PEROXIDASE; PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RATS; RATS, SPRAGUE-DAWLEY; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867322341     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2251     Document Type: Article

References (27)

1. Fuchikami J, Takahashi M: Cigarette smoke-induced animal models to evaluate drug efficacy on chronic obstructive pulmonary disease (COPD). Nihon Yakurigaku Zasshi 2006;127:183-189.
2. Wright JL, Churg A: Animal models of cigarette smoke-induced COPD. Chest 2002;122:301S-306S.
3. Silva BF, Valenca SS, Lanzetti M, Pimenta, WA, Castro P, Goncalves KV, Porto LC: Alpha-tocopherol and ascorbic acid supplementation reduced acute lung inflammatory response by cigarette smoke in mouse. Nutrition 2006;22:1192-1201.
4. Lixuan Z, Jingcheng D, Wenqin Y, Jianhua H, Baojun L, Xiaotao F: Baicalin attenuates inflammation by inhibiting NF-jB activation in cigarette smoke induced inflammatory models. Pulm Pharmacol Ther 2010;23:411-419.
5. Castro P, Nasser H, Abrahao A, Dos RL, Rica I, Valenca SS, Rezende DC, Quintas LE, Cavalcante MC, Porto LC, Koatz VL: Aspirin and indomethacin reduce lung inflammation of mice exposed to cigarette smoke. Biochem Pharmacol 2009;77:1029-1039.
6. Mikura S, Wada H, Higaki M, Yasutake T, Ishii H, Kamiya S, Goto H: Erythromycin prevents the pulmonary inflammation induced by exposure to cigarette smoke. Transl Res 2011;158: 30-37.
7. Tamimi A, Serdarevic D, Hanania NA: The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Respir Med 2012;106:319-328.
8. Wang H, Ye Y, Zhu M, Cho C: Increased interleukin-8 expression by cigarette smoke extract in endothelial cells. Environ Toxicol Pharmacol 2000;9:19-23.
9. Kent L, Smyth L, Clayton C, Scott L, Cook T, Stephens R, Fox S, Hext P, Farrow S, Singh D: Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages. Cytokine 2008;42:205-216.
10. Conti P, Kempuraj D, Kandere K, Di Gioacchino M, Barbacane RC, Castellani ML, Felaco M, Boucher W, Letourneau R, Theoharides TC: IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett 2003;86:123-129.
11. Wang YJ, Jiang YL, Tang HF, Zhao CZ, Chen JQ: Zl-n-91, a selective phosphodiesterase 4 inhibitor, suppresses inflammatory response in a COPD-like rat model. Int Immunopharmacol 2010; 10:252-258.
12. Jain M, Parmar HS: Evaluation of antioxidative and antiinflammatory potential of hesperidin and naringin on the rat air pouch model of inflammation. Inflamm Res 2011;60:483-491.
13. Bodas R, Prieto N, Lopez-Campos O, Giraldez FJ, Andres S: Naringin and vitamin E influence the oxidative stability and lipid profile of plasma in lambs fed fish oil. Res Vet Sci 2011;91:98-102.
14. Golechha M, Chaudhry U, Bhatia J, Saluja D, Arya DS: Naringin protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory and neuroprotective intervention. Biol Pharm Bull 2011;34:360-365.
15. Liu Y, Wu H, Nie YC, Chen JL, Su WW, Li PB: Naringin attenuates acute lung injury in LPS-treated mice by inhibiting NFkappaB pathway. Int Immunopharmacol 2011;11:1606-1612.
16. Kanno S, Shouji A, Tomizawa A, Hiura T, Osanai Y, Ujibe M, Obara Y, Nakahata N, Ishikawa M: Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages. Life Sci 2006;78:673-681.
17. Zheng H, Liu Y, Huang T, Fang Z, Li G, He S: Implication of cyclic nucleotide phosphodiesterase inhibition in the vasorelaxant activity of the citrus-fruits flavonoid ( + /-)-naringenin. Planta Med 2005;71:99-107.
18. Zheng H, Liu Y, Huang T, Fang Z, Li G, He S: Development and characterization of a rat model of chronic obstructive pulmonary disease (COPD) induced by sidestream cigarette smoke. Toxicol Lett 2009;189:225-234.
19. Onoue S, Misaka S, Aoki Y, Karaki S, Kuwahara A, Ohide A, Mizumoto T, Yamada S: Inhalable powder formulation of vasoactive intestinal peptide derivative, [R15,20,21, L17]-VIPGRR, attenuated neutrophilic airway inflammation in cigarette smoke-exposed rats. Eur J Pharm Sci 2010;41:508-514.
20. Wollin L, Pieper MP: Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD. Pulm Pharmacol Ther 2010;23:345-354.
21. Pustovrh MC, Jawerbaum A, Capobianco E, White V, Martinez N, Lopez-Costa JJ, Gonzalez E: Oxidative stress promotes the increase of matrix metalloproteinases-2 and-9 activities in the feto-placental unit of diabetic rats. Free Radic Res 2005;39: 1285-1293.
22. Fu X, Kao JL, Bergt C, Kassim SY, Huq NP, d'Avignon A, Parks WC, Mecham RP, Heinecke JW: Oxidative cross-linking of tryptophan to glycine restrains matrix metalloproteinase activity: specific structural motifs control protein oxidation. J Biol Chem 2004;279:6209-6212.
23. Egi K, Conrad NE, Kwan J, Schulze C, Schulz R, Wildhirt SM: Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts. Eur J Cardiothorac Surg 2004;26:262-269.
24. Noirey N, Staquet MJ, Gariazzo MJ, Serres M, Andre C, Schmitt D, Vincent C: Relationship between expression of matrix metalloproteinases and migration of epidermal and in vitro generated Langerhans cells. Eur J Cell Biol 2002;81:383-389.
25. Goswami B, Rajappa M, Mallika V, Shukla DK, Kumar S: TNFalpha/ IL-10 ratio and C-reactive protein as markers of the inflammatory response in CAD-prone North Indian patients with acute myocardial infarction. Clin Chim Acta 2009;408:14-18.
26. Lim S, Roche N, Oliver BG, Mattos W, Barnes PJ, Chung KF: Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. Am J Respir Crit Care Med 2000;162:1355-1360.
27. Caramori G, Adcock I: Pharmacology of airway inflammation in asthma and COPD. Pulm Pharmacol Ther 2003;16:247-277.